Cardimet MR 35 mg (Tablet (Modified Release))
Unit Price: ৳ 8.00 (3 x 14: ৳ 336.00)
Strip Price: ৳ 112.00
Medicine Details
Category | Details |
---|---|
Generic | Trimetazidine dihydrochloride |
Company | Eskayef pharmaceuticals ltd |
Indications
- Add-on therapy for symptomatic treatment of stable angina pectoris in adults
Pharmacology
- First 3-keto acyl CoA thiolase inhibitor
- Metabolic anti-ischemic agent
- Inhibition of fatty acid pathway
- Enhancement of glucose pathway efficiency
- Prevention of lactic acid production
Dosage & Administration
- Recommended dose of 35 mg twice daily or 20 mg thrice daily during meals
- Assessment of treatment benefit after three months
- Discontinuation in absence of treatment response
Interaction
- No reported drug interactions so far
- No interactions with beta-blockers, calcium antagonists, nitrates, heparin, hypolipidemic agents, or digitalis preparation
Contraindications
- Hypersensitivity to the active substance or excipients
- Presence of Parkinson's disease or related symptoms
- Severe renal impairment
Side Effects
- Common side effects include dizziness, headache, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, rash, pruritus, urticaria, and asthenia
Pregnancy & Lactation
- Preferable avoidance during pregnancy
- Unknown excretion in human milk
- Risk to newborns/infants during breastfeeding
Precautions & Warnings
- Not a curative treatment for angina attacks
- Not an initial treatment for unstable angina pectoris
- Not a treatment for myocardial infarction
Therapeutic Class
- Other Anti-anginal & Anti-ischaemic drugs
Storage Conditions
- Keep in a dry place away from light and heat
- Keep out of the reach of children
Related Brands
- Angivas MR 35 mg (Tablet (Modified Release)) - popular-pharmaceuticals-ltd
- Trangit MR 35 mg (Tablet (Modified Release)) - sandoz-a-novartis-division
- Angitrim MR 35 mg (Tablet (Modified Release)) - globe-pharmaceuticals-ltd
- Anginox MR 35 mg (Tablet (Modified Release)) - general-pharmaceuticals-ltd
- Trangina MR 35 mg (Tablet (Modified Release)) - biopharma-limited